Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
2007 |
| gptkbp:associatedWith |
gptkb:modafinil
|
| gptkbp:ATCCode |
N06BA14
|
| gptkbp:brand |
armodafinil
|
| gptkbp:chemicalFormula |
gptkb:C15H15NO2S
|
| gptkbp:controlledSubstanceSchedule |
Schedule IV (US)
|
| gptkbp:eliminationHalfLife |
12-15 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nuvigil
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
wakefulness-promoting agent
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache insomnia dry mouth |
| gptkbp:usedFor |
gptkb:shift_work_sleep_disorder
narcolepsy obstructive sleep apnea treatment of excessive sleepiness |
| gptkbp:bfsParent |
gptkb:Cephalon
gptkb:Teva_Neuroscience |
| gptkbp:bfsLayer |
7
|